Overall survival rates (OS) of childhood cancer in mainland France over 2000-2016, by diagnostic groups and sub. |
|||||||
Taux de survie (IC95%) |
|||||||
Diagnostic groups and subgroups |
N |
1y-OS |
2y-OS |
5y-OS |
|||
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases |
8503 |
94.1 |
[93.6-94.6] |
90.4 |
[89.7-91.0] |
86.1 |
[85.3-86.8] |
I.a Lymphoid leukemias |
6678 |
96.4 |
[95.9-96.8] |
93.8 |
[93.1-94.3] |
90.0 |
[89.3-90.7] |
I.b Acute myeloid leukemias |
1231 |
84.6 |
[82.5-86.5] |
76.6 |
[74.1-78.9] |
70.2 |
[67.5-72.7] |
II. Lymphomas and reticuloendothelial neoplasms |
3258 |
96.9 |
[96.3-97.5] |
95.4 |
[94.6-96.1] |
94.3 |
[93.4-95.1] |
II.a Hodgkin lymphomas |
1480 |
99.6 |
[99.1-99.8] |
98.8 |
[98.0-99.2] |
97.7 |
[96.8-98.4] |
II.b Non-Hodgkin lymphomas (except Burkitt lymphomas) |
983 |
94.6 |
[93.0-95.9] |
91.4 |
[89.4-93.0] |
89.5 |
[87.4-91.3] |
II.c Burkitt lymphomas |
788 |
94.9 |
[93.1-96.3] |
94.3 |
[92.4-95.7] |
94.0 |
[92.0-95.4] |
III. CNS and miscellaneous intracranial and intraspinal neoplasms |
7500 |
85.7 |
[84.9-86.5] |
79.3 |
[78.4-80.2] |
74.4 |
[73.4-75.4] |
III.a Ependymomas and choroid plexus tumors |
709 |
91.4 |
[89.0-93.2] |
85.9 |
[83.1-88.2] |
74.6 |
[71.1-77.8] |
III.b Astrocytomas |
2798 |
92.7 |
[91.7-93.6] |
88.8 |
[87.6-89.9] |
87.0 |
[85.6-88.2] |
III.c Intracranial and intraspinal embryonal tumors |
1422 |
75.4 |
[73.1-77.6] |
66.0 |
[63.4-68.4] |
55.7 |
[53.0-58.4] |
III.d Other gliomas |
1017 |
62.3 |
[59.2-65.2] |
44.8 |
[41.7-47.8] |
38.7 |
[35.6-41.7] |
III.e Other specified intracranial and intraspinal neoplasms |
1436 |
97.7 |
[96.8-98.4] |
96.5 |
[95.4-97.4] |
95.3 |
[94.1-96.3] |
IV. Neuroblastomas and other peripheral nervous cell tumors |
2404 |
92.0 |
[90.8-93.0] |
85.6 |
[84.1-86.9] |
76.4 |
[74.6-78.1] |
IV.a Neuroblastomas and ganglioneuroblastomas |
2372 |
92.0 |
[90.8-93.0] |
85.5 |
[84.0-86.9] |
76.2 |
[74.4-77.9] |
V. Retinoblastomas |
849 |
99.5 |
[98.7-99.8] |
99.5 |
[98.7-99.8] |
99.3 |
[98.4-99.7] |
VI. Renal tumors |
1637 |
96.8 |
[95.8-97.6] |
94.5 |
[93.3-95.5] |
92.7 |
[91.3-93.9] |
VI.a Nephroblastomas and other nonepithelial renal tumors |
1583 |
97.0 |
[96.0-97.7] |
94.8 |
[93.6-95.8] |
93.0 |
[91.6-94.2] |
VII. Hepatic tumors |
304 |
90.4 |
[86.5-93.3] |
86.5 |
[82.1-89.8] |
83.1 |
[78.4-87.0] |
VII.a Hepatoblastomas |
256 |
91.0 |
[86.8-93.9] |
86.3 |
[81.4-90.0] |
85.4 |
[80.5-89.2] |
VIII. Malignant bone tumors |
1422 |
94.4 |
[93.1-95.5] |
87.0 |
[85.1-88.6] |
74.1 |
[71.7-76.4] |
VIII.a Osteosarcomas |
660 |
93.0 |
[90.8-94.7] |
85.7 |
[82.7-88.1] |
71.3 |
[67.5-74.7] |
VIII.c Ewing tumors and related bone sarcomas |
657 |
95.9 |
[94.1-97.2] |
87.9 |
[85.2-90.2] |
75.4 |
[71.8-78.7] |
IX. Soft tissue and other extraosseous sarcomas |
1882 |
90.2 |
[88.7-91.4] |
81.8 |
[80.0-83.5] |
72.5 |
[70.4-74.6] |
IX.a Rhabdomyosarcomas |
1019 |
92.5 |
[90.7-94.0] |
83.5 |
[81.0-85.6] |
73.0 |
[70.1-75.7] |
IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms |
139 |
92.8 |
[87.0-96.1] |
87.1 |
[80.2-91.6] |
81.2 |
[73.3-86.9] |
IX.d Other specified soft tissue sarcomas |
579 |
86.2 |
[83.1-88.7] |
79.4 |
[75.9-82.5] |
70.9 |
[66.9-74.5] |
IX.e Unspecified soft tissue sarcomas |
141 |
86.5 |
[79.7-91.2] |
74.4 |
[66.4-80.8] |
66.8 |
[58.1-74.1] |
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads |
1113 |
96.5 |
[95.2-97.4] |
95.0 |
[93.5-96.1] |
94.1 |
[92.5-95.3] |
X.a Intracranial and intraspinal germ cell tumors |
423 |
96.6 |
[94.4-98.0] |
95.1 |
[92.6-96.8] |
94.3 |
[91.6-96.2] |
X.b Malignant extracranial and extragonadal germ cell tumors |
291 |
93.5 |
[90.0-95.8] |
92.1 |
[88.3-94.7] |
90.9 |
[86.9-93.7] |
X.c Malignant gonadal germ cell tumors |
369 |
98.9 |
[97.1-99.6] |
98.3 |
[96.4-99.3] |
97.8 |
[95.6-98.9] |
XI. Other malignant epithelial neoplasms and malignant melanomas |
1024 |
96.5 |
[95.1-97.5] |
95.0 |
[93.4-96.2] |
93.3 |
[91.5-94.7] |
XI.b Thyroid carcinomas |
411 |
99.3 |
[97.7-99.8] |
99.3 |
[97.7-99.8] |
99.0 |
[97.3-99.6] |
XI.d Malignant melanomas |
186 |
92.3 |
[87.4-95.4] |
91.2 |
[86.0-94.5] |
87.4 |
[81.5-91.5] |
XII. Other and unspecified malignant neoplasms |
70 |
86.6 |
[75.8-92.8] |
80.5 |
[68.9-88.2] |
78.9 |
[67.0-86.9] |
All cancers (excluding Langherhans cell histiocytosis) |
29966 |
92.3 |
[92.0-92.6] |
87.8 |
[87.4-88.2] |
83.1 |
[82.6-83.5] |
Langherhans cell histiocytosis |
118 |
93.9 |
[87.7-97.1] |
93.1 |
[86.6-96.5] |
93.1 |
[86.6-96.5] |
All cancers (including Langherhans cell histiocytosis) |
30084 |
92.3 |
[92.0-92.6] |
87.8 |
[87.4-88.2] |
83.1 |
[82.7-83.5] |